News
Zacks Investment Research on MSN5h
PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?Shares of Prothena Corporation PRTA plummeted 53.5% year to date compared with the industry’s decline of 0.6%. The recent ...
Clinical Trials Arena on MSN7h
Headlands Research acquires Puerto Rico’s clinical research siteThe move helps in expediting the enrolment process for central nervous system, vaccine, as well as specialty trials.
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback